Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Columnist Dagmar Munn turns to affirmations and positive self-talk on those occasional days when she feels shut down.

The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...

ALS is a disease of continual losses and trade-offs. We walk a tightrope between safety and independence, and caution and quality of life.

New York was the only state to receive the highest mark on the ALS Association’s latest report cards, the association said.

ALS took many things from columnist Juliet Taylor's late husband, Jeff, including the end of his career, which was ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...

Riluzole treatment and a diet containing high glycemic index foods interact 'synergistically' to slow ALS progression, ...

The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...